ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Wins Journalism Award

April 1, 2011

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999